Kolexia
Faivre Sandrine Oncologie médicale
Faivre Sandrine
Oncologie médicale
Hôpital Beaujon
Clichy, France
257 Activités
88 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome hépatocellulaire Tumeurs du foie Carcinome épidermoïde Tumeurs neuroendocrines Tumeurs du pancréas Tumeurs de la tête et du cou Métastase tumorale Carcinome épidermoïde de la tête et du cou

Collaborateurs

Voir plus
Raymond Eric
Raymond Eric
Gh Paris Site Saint Joseph, Paris, France
Dreyer Chantal
Dreyer Chantal
Gh Paris Site Saint Joseph, Paris, France
Bouattour Mohamed
Bouattour Mohamed
Hôpital Beaujon, Clichy, France
Paradis Valerie
Paradis Valerie
Hôpital Beaujon, Clichy, France

Industries

Voir plus
MSD
20 collaboration(s)
Dernière en 2023
Ipsen
8 collaboration(s)
Dernière en 2021
Roche
7 collaboration(s)
Dernière en 2021
Bayer
3 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment.
Bulletin du cancer   27 février 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level Amplification: Preclinical and Clinical Evidence.
JCO precision oncology   16 février 2024
National standard for the treatment of squamous cell carcinoma of upper aerodigestive tract.
Bulletin du cancer   08 février 2024
iMonitORL: Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies
Essai Clinique (Centre Hospitalier Saint Joseph Saint Luc)   27 novembre 2023
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040): A Phase III Randomized Trial of MK-3475 (Pembrolizumab) Versus Standard Treatment in Subjects With Recurrent or Metastatic Head and Neck Cancer
Essai Clinique (Merck & Co.)   30 juin 2023
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study.
Cancers   17 septembre 2022
Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141): An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Essai Clinique (BMS)   06 septembre 2022
c-Met Second-Line Hepatocellular Carcinoma: A Multicenter, Single Arm, Phase Ib/II Study to Evaluate Efficacy, Safety, and PK of MSC2156119J as Monotherapy in Subjects With MET+ Advanced Hepatocellular Carcinoma With Child Pugh Class A Liver Function Who Have Failed Sorafenib Treatment
Essai Clinique (Merck KGaA)   22 août 2022
The MUSES∗: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment: ∗MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers.
European journal of cancer (Oxford, England : 1990)   17 juin 2022
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.
Targeted oncology   14 octobre 2021